|
ARHGAP29 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.521600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.782300E-02 |
| Normal-vs-Stage2 |
5.879000E-03 |
| Normal-vs-Stage3 |
4.757200E-03 |
| Normal-vs-Stage4 |
1.56539999999206E-05 |
| Stage1-vs-Stage2 |
2.318800E-01 |
| Stage1-vs-Stage3 |
2.637800E-01 |
| Stage1-vs-Stage4 |
2.181700E-03 |
| Stage2-vs-Stage3 |
7.098000E-01 |
| Stage2-vs-Stage4 |
2.630000E-01 |
| Stage3-vs-Stage4 |
8.798300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.742300E-03 |
| Normal-vs-AfricanAmerican |
4.040000E-01 |
| Normal-vs-Asian |
1.730380E-02 |
| Caucasian-vs-AfricanAmerican |
5.571400E-01 |
| Caucasian-vs-Asian |
6.489600E-01 |
| AfricanAmerican-vs-Asian |
4.512800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.701400E-03 |
| Normal-vs-Female |
3.500600E-03 |
| Male-vs-Female |
4.651200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.163150E-01 |
| Normal-vs-Age(41-60Yrs) |
1.818820E-03 |
| Normal-vs-Age(61-80Yrs) |
1.426500E-04 |
| Normal-vs-Age(81-100Yrs) |
1.002000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.136200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.496300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.727800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.388810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.334000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.329600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.141100E-03 |
| Classical-VS-Follicular |
1.181200E-04 |
| Classical-VS-Other |
1.444170E-01 |
| Classical-VS-Normal |
8.418200E-02 |
| Tall-VS-Follicular |
4.266200E-01 |
| Tall-VS-Other |
4.497400E-01 |
| Tall-VS-Normal |
7.206600E-04 |
| Follicular-VS-Other |
8.190400E-01 |
| Follicular-VS-Normal |
4.27989999995937E-06 |
| Other-VS-Normal |
1.284460E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.042300E-04 |
| Normal-vs-N1 |
2.244200E-02 |
| N0-vs-N1 |
7.344600E-01 |
|
|
